Krystal Biotech, Inc. KRYS Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s work in process?
- Krystal Biotech, Inc. (KRYS) reported work in process of $15.12M in Q1 2026.
- How has Krystal Biotech, Inc.'s work in process changed year-over-year?
- Krystal Biotech, Inc.'s work in process increased by 69.7% year-over-year, from $8.91M to $15.12M.
- What is the long-term trend for Krystal Biotech, Inc.'s work in process?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s work in process has grown at a 118.0% compound annual growth rate (CAGR), from $3.2M to $15.22M.